Claudin 2 Protein (CLDN2) (Myc-DYKDDDDK Tag)
Quick Overview for Claudin 2 Protein (CLDN2) (Myc-DYKDDDDK Tag) (ABIN2712855)
Target
See all Claudin 2 (CLDN2) ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Purification tag / Conjugate
- This Claudin 2 protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human Claudin-2 / CLDN2 protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System HEK-293 CellsConjugate His tagOrigin HumanPrice starts at $16,231.82Expression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $20,480.57Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- Claudin 2 (CLDN2)
-
Alternative Name
- Claudin-2,cldn2
-
Background
- This gene product belongs to the claudin protein family whose members have been identified as major integral membrane proteins localized exclusively at tight junctions. Claudins are expressed in an organ-specific manner and regulate tissue-specific physiologic properties of tight junctions. This protein is expressed in the intestine. Alternatively spliced transcript variants with different 5' untranslated region have been found for this gene.[provided by RefSeq, Jan 2010].
-
Molecular Weight
- 24.4 kDa
-
NCBI Accession
- NP_065117
-
Pathways
- Hepatitis C
Target
-